INTRODUCTION

Top Abstract Introduction Materials and Methods Results Discussion References

Adenoviruses (Ads) are among the best-characterized viral systems (24, 49). Both past and ongoing Ad studies have significantly contributed to concepts in molecular and cellular biology and have facilitated the development of Ad vectors for preclinical and clinical trials (3). Ads are nonenveloped icosahedral particles of about 90 nm in diameter (8). The main capsid component is the facette-associated hexon protein, which is assembled and stabilized by various minor proteins. Hexon largely protects a double-stranded linear DNA genome, which is packed inside the capsid together with additional viral proteins including the cysteine protease L3/p23. The bases of the capsid vertices are built from the penton base protein from which fibers emanate. Of the six Ad subgroups, comprising almost 50 serotypes, the subgroup C viruses such as Ad2 and Ad5 have been studied the most extensively. It was realized relatively early that subgroup C Ad entry requires two receptors, a primary receptor, CAR (coxsackie-adenovirus receptor), for attachment (4, 56) and secondary receptors, _v5 or _v3 integrins, for internalization (62). While the primary receptor determines virus tropism and is a major aim in current retargeting studies of Ad (for a recent review, see reference 12), the secondary receptor plays more subtle but less well understood roles in the infection process. Besides facilitating virus internalization, most probably via clathrin-coated pits (41, 58), _v5 integrins contribute to Ad-dependent permeabilization of the plasma membrane (61), activation of phosphatidylinositol 3-OH kinase (29), and small G proteins of the Rho family (28) and the activation of the Raf/extracellular receptor kinase 1 and 2 (ERK1,2) pathway (6). While the mitogen-activated protein kinase pathway of ERK1,2 is not required for Ad entry, activated integrins play a role in virus uptake and intracellular transport.

Endocytosis of Ad requires integrins, assembly of clathrin-coated pits, and invagination and fission of the plasma membrane, followed by routing of the emerging vesicle toward early endosomes. The entire process is regulated by lipid kinases, actin-modulating small GTPases, and the large GTPase dynamin (28, 29). Like Ad endocytosis, integrin-mediated endocytosis is complex and can involve the recruitment of the clathrin internalization machinery, dynamin (38, 48), dynamic rearrangement of cortical actin filaments, and, finally, vesicular movement through the cell cortex controlled by lipid and protein kinases and small GTPases (27, 36, 51). Unlike physiological extracellular integrin ligands, internalized Ad2 escapes from acidified endocytic vesicles (5, 41). It is then translocated as a naked particle along microtubules to the nucleus (54) and docks at nuclear pore complexes (9), where the capsid is disassembled (20) and the DNA genome is imported into the nucleoplasm (19).

In contrast to wild-type (wt) Ad2, an Ad2 mutant, ts1, fails to escape from the endocytic system (33, 60). ts1 has a point mutation in the L3/p23 protease, preventing protease packaging and proper processing of the viral capsid structure at the restrictive temperature (for a review, see reference 18). After passing the cell cortex, ts1 endosomes are transported to a perinuclear region by microtubule-dependent motors (54) and ts1 is eventually degraded in lysosomes (20). Part of the reason why ts1 fails to escape from endosomes could be the failure to release fibers, although it binds to CAR and internalizes via integrins much like wt Ad2 (20, 29). Here we have analyzed cellular requirements for the first step of wt Ad2 disassembly, the release of the fibers. We show that besides cortical actin filaments, integrins play a crucial role in detaching fibers at the cell surface. Following fiber detachment, Ad2 is endocytosed and transported through the actin cortex in a protein kinase C (PKC)-dependent fashion to finally escape from endosomes and reach the cytosol.

	MATERIALS AND METHODS

Top Abstract Introduction Materials and Methods Results Discussion References

Cells, viruses, and infections. HeLa cells (American Type Culture Collection) were grown on glass coverslips or 30-mm-diameter petri dishes in Dulbecco's modified Eagle's medium (DMEM) (Gibco-BRL) containing 7% fetal calf serum (HyClone) and L-glutamine in a humidified 5% CO₂-air atmosphere. In some experiments, cells were treated for 30 min at 37°C in growth medium with 2 µM cytochalasin D (CD) (Calbiochem, Juro Supply) 180 nM jasplakinolide (Jas) (a gift from Phil Crews, Santa Cruz, Calif.), 0.5 mM cyclic arginine-glycine-aspartate peptide (cRGD) (a gift from J. Glass, Telios Pharmaceuticals, San Diego, Calif.), 1 mM linear arginine-glycine-glutamate-serine peptide (RGES) (Sigma), the PKC inhibitor calphostin C (5 µM) (Calbiochem, Juro Supply) or bisindolylmaleimide (BIM) (5 µM) (Sigma, Fluka), the myristoylated pseudosubstrate of PKC and PKC (10 µg/ml) (Promega, Catalys AG), which inhibits all classical PKCs, or a control myristoylated autocamptide-related inhibitory peptide (10 µg/ml) (Calbiochem, Juro Supply). The cold-synchronized infection with Ad in RPMI-bovine serum albumin (BSA) medium containing drugs was followed by a warming period in DMEM-0.2% BSA containing drugs as indicated.

Quantitative fluorescence microscopy. Cell-associated Ad2-TR was quantitated in the cell periphery, in the cytoplasm, and at the nucleus as described previously (37). In brief, HeLa cells were infected with Ad2-TR, fixed with 3% paraformaldehyde in phosphate-buffered saline, permeabilized for 2 min with 0.5% Triton X-100 in phosphate-buffered saline including 20 mM ammonium chloride to reduce autofluorescence, and stained for the nuclear DNA with 4,6-diamidino-2-phenylindole (DAPI) (0.5 µg/ml) (Sigma), and for the plasma membrane Ca-ATPase 1 with an affinity-purified antibody kindly provided by D. Guerini (ETH Zurich) (53) and goat anti-rabbit immunoglobulin G coupled to Alexa 488 (Molecular Probes, Leiden, The Netherlands). Specimens were embedded in 0.2% p-phenylendiamine-0.02 M Tris-HCl-85% glycerol (pH 8.8) and analyzed by fluorescence microscopy using an inverted motorized Leica DMIRBE microscope equipped with a 100× objective (N.A. 1.3 PL Fluotar) and a back-illuminated MicroMax-controlled charge-coupled device camera (800 by 1,000 pixels of 15 by 15 µm [Princeton Instruments, Visitron GmbH]), which was operated in 16-bit mode at 25°C. Excitation occurred through band-pass excitation filters for DAPI (330/80; Omega XF03), Alexa 488 (475/40; Omega XF100), and TR (560/55; Omega XF101), and emitted light was collected either through a single-pass (DAPI, 425LP, dichroic 400; Omega XF03) or a double-pass (green and red, 528/30 and 633/60; dichroic 490/575; Omega XF53) emission filter. The TR images were recorded sequentially throughout the entire cell sample (z-stack) at 1-µm steps. Alexa 488, DAPI, and differential interference contrast images were obtained from sections toward the cell bottom or the middle to indicate cell and nuclear dimensions, respectively. Each TR image was processed by fast Fourier transformation (FFT) to remove out-of-focus information and to correct for uneven illumination as described previously (37). FFT-processed images were merged using the summation function, and background was subtracted by setting the lowest pixel value to 0. Pixel values of TR were determined in regions of interest, which were defined by a thresholding function using the plasma membrane and the nuclear strains, respectively.

CLSM. Confocal laser-scanning microscopy (CLSM) was performed with a confocal unit (TCS SP; Leica), on an inverted microscope (Leica DMIRBE) using the 63× lens (N.A. 1.32). Optical sections were collected at step sizes of 0.5 µm. For DAPI imaging, a UV laser with excitation lines at 351 and 364 nm was used. For detection of the emission, the spectrophotometer was set to 410 to 530 nm. The plasma membrane marker Ca ATPase 1 was visualized by indirect immunofluorescence using an Alexa 488-tagged secondary antibody. Alexa 488- and TR-coupled Ad2 were recorded with the 488- and 568-nm laser lines of an argon/krypton laser, respectively. The settings of the spectrophotometer were 495 to 560 nm for Alexa 488 and 580 to 640 nm for TR. The pinhole for all recordings was set to 1.0. Images of the three fluorochromes were taken sequentially to exclude cross talk between the channels.

EM. Electron microscopy (EM) was carried out as described previously (54). For quantification, micrographs were recorded in sections across the middle of the cells by a slow-scan charge-coupled device camera (Gatan, Gloor AG) at ×30,000 magnification using the DigitalMicrograph software package (version 3.3.1; Gatan, Pleasanton, Calif.). Morphometry of single sections from 11 to 14 randomly selected entire cells was carried out for each of the drug conditions as specified. All the cell-associated virus particles were quantitated. This required 90 to 179 micrographs depending on the number of virus particles present in the analyzed cells.

Statistics. Statistical analyses were conducted using a one-sided t test with indicated confidence intervals, standard error of the mean (SEM), and sample size (n).

	RESULTS

Top Abstract Introduction Materials and Methods Results Discussion References

Dissociation of the fibers from the capsid is the first event in the stepwise uncoating program of Ad2 (21). Although it coincides with virus endocytosis, the cellular requirements or functional implications are unknown.

Cellular requirements for fiber release. Since Ad uptake into cells requires an intact actin cytoskeleton and is facilitated by _v integrins (28, 42), we first analyzed whether filamentous actin (F-actin) and integrins were implicated in fiber release from incoming Ad2. To disrupt actin filaments, HeLa cells were treated with CD, which caps F-actin, stimulates ATP hydrolysis on globular actin, and also affects the small G protein rho A (44, 47). Alternatively, cells were incubated in low concentrations of Jas, which binds to and stabilizes F-actin in a similar fashion to the cell-impermeable phalloidin (7, 11). The efficiency of CD in disrupting F-actin and the ability of Jas to bind to F-actin were examined by staining cells with phalloidin-Alexa 488 following fixation with paraformaldehyde and permeabilization with Triton X-100. Jas-treated cells showed no phalloidin staining at all, although stress fibers and cortical actin were readily visualized using anti-actin antibodies (data not shown). CD-treated cells contained large amounts of phalloidin-positive actin aggregates. To measure fiber release, [³⁵S]methionine-labeled Ad2 was bound to drug-treated cells in the cold and internalized at 37°C for 0, 15, or 30 min. Immunocomplexes containing fiber epitopes were collected from Empigen-lysed cells using a specific antifiber antibody (R72,2), which recognizes intact Ad2 particles (21). The amounts of immunoadsorbed [³⁵S]methionine-labeled fiber and coprecipitated hexon were quantitated by SDS-PAGE and PhosphorImager analysis as described earlier (21). The hexon-to-fiber ratio derived from intact [³⁵S]methionine-labeled virus (not incubated with cells) was set to 100% (Fig. 1, lane 1). As expected, control cells efficiently promoted the dissociation of fiber from hexon within 30 min (more than sixfold) and with a half-maximal efficiency at 12 min postinfection (p.i.) (lanes 2 to 4). In contrast, fiber dissociation from hexon was slowed in CD-treated cells, reaching half-maximal efficiencies after 30 min of warming (lanes 5 to 7). However, no delay of fiber release was detected in infections in Jas-treated cells (lanes 8 to 10), suggesting that fiber release is promoted by an intact rather than dynamic F-actin cytoskeleton. We then asked if integrins were directly or indirectly involved in triggering fiber release. Cells were incubated with cRGD peptides or control RGE peptides to inhibit Ad2 endocytosis (1, 62), and fiber dissociation was determined as described above. The results demonstrated that cRGD peptides were efficient inhibitors, since control RGE peptides had no effect on fiber release (lanes 11 to 16). The data showed that fiber release correlated with virus uptake and required an intact actin cytoskeleton.

View larger version (49K): [in this window] [in a new window]   FIG. 1.   Fiber release from incoming Ad2 depends on intact F-actin and is inhibited by RGD peptides but not PKC inhibitors. HeLa cells were treated with the indicated inhibitors for 30 min at 37°C and then incubated with [35S]methionine-labeled Ad2 in the cold for 1 h and warmed for different times as indicated. Cell lysates were immunoprecipitated with antifiber antibodies under nondissociating conditions and fractionated by SDS-PAGE. [35S]methionine in hexon (Hex) and fiber (Fib) was quantitated and expressed as a ratio of hexon to fiber by using purified [35S]methionine-labeled Ad2 as a standard (100%). The data are representative of at least two independent experiments.

Fiber release occurs at the cell surface. To test if Ad uptake was required for fiber release from incoming capsids, we examined Ad2 endocytosis by three different assays, a biochemical cell surface trypsinization assay, a quantitative combined CLSM-fluorescence microscopy assay, and quantitative EM. In the first assay, [³⁵S]methionine-labeled Ad2 was bound to CD- or Jas-treated cells and the amount of trypsin-resistant hexon was determined at different times of infection (21). Since this assay measures the trypsin accessibility of the major capsid protein hexon at 4°C, it estimates the amount of protease-sensitive virus on the cell surface. Note, however, that the trypsinizations did not remove virus particles from control cells (Fig. 2A, and D), although the hexons were quantitatively cleaved at the potential trypsin cleavage sites in loop 1 near the N terminus (26). Using this assay, typical times for half-maximal Ad2 internalization (t_1/2) into control cells were around 10 to 12 min and efficiencies were near 80% at 60 min p.i. (Fig. 2A and G). Disruption of the actin cytoskeleton by CD, however, completely blocked the appearance of trypsin-resistant hexon up to 60 min p.i. (Fig. 2B and G), consistent with earlier results (28).

View larger version (78K): [in this window] [in a new window]   FIG. 2.   Cell surface trypsinization assay of incoming [35S]methionine-labeled Ad2 in cells treated with actin and PKC inhibitors. HeLa cells were treated with various inhibitors for 30 min, and then [35S]methionine-labeled Ad2 was bound for 60 min in the cold. The cells were warmed for different times as indicated and treated with cold trypsin to probe for surface accessibility of hexon. The ratio of intact (Hex) to cleaved (Hex') hexon was determined after SDS-PAGE (A to F) and plotted for each condition, taking the sum of the cleaved and uncleaved hexons from cells not treated with trypsin (T) as 100% (G and H). Controls not treated with trypsin are shown in panels A, B, D, and F. Dashed lines in panels G and H indicate the total hexon radioactivity, and solid lines show the trypsin-resistant hexon determined by PhosphorImager analysis. Symbols for different drug treatments are used as indicated in panels G and H. Representative data from at least two independent experiments are shown.

View larger version (26K): [in this window] [in a new window]   FIG. 3.   CLSM analysis of incoming Ad2-TR in cells treated with actin and PKC inhibitors reveals the actin and PKC requirements for nuclear transport of Ad2. TR-labeled Ad2 (red) was bound to HeLa cells pretreated with drugs or not pretreated and internalized for 0 min (A) or 60 min (B to E) as indicated in Materials and Methods. CLSM sections sampling the entire cell were generated for the TR channel and the Alexa 488 channel (plasma membrane Ca ATPase 1 [green]) and projected en face. The limits of the nucleus as determined by DAPI staining (results not shown) are indicated by a white trace. A single representative cell for each of the conditions is shown.

View larger version (41K): [in this window] [in a new window]   FIG. 4.   Quantitative subcellular analysis of incoming fluorescently labeled wt Ad2 and ts1 Ad2 in cells treated with actin- or PKC-directed inhibitors. Ad2-TR was cold bound to inhibitor-treated or control HeLa cells and internalized for 0 min (open bars) or 60 or 70 min (solid bars) as described in Materials and Methods. The cells were fixed and analyzed for virus fluorescence in the cell periphery, the cytoplasm, and the nucleus by using an image deconvolution routine described previously (37). Results are shown as mean fluorescence values, with the corresponding SEM derived from the indicated number of analyzed cells (n). (A) Results for wt Ad2-TR in actin-inhibited cells. (B and C) Results for wt and ts1 Ad2-TR in cells not treated with drugs (solid bars) or treated with the PKC inhibitor PKC-myr (stippled bars) or a control myristoylated autocamptide (autocamp) directed against Cam kinase II (striped bars).

View larger version (168K): [in this window] [in a new window]   FIG. 5.   Thin-section electron microscopy of wt Ad2-infected HeLa cells treated with actin- or PKC-directed inhibitors. Cells were treated with drugs as described in Materials and Methods and incubated with 50 µg of purified Ad2 per ml for 60 min in the cold. Unbound virus (approximately 98 to 99% of input virus) was washed off, and the cells were incubated with or without inhibitors for 30 min at 37°C, fixed, and processed for thin-section EM. (A) control cell infected without drugs. (B) CD-treated cell. (C) Jas-treated cell. (D) PKC-myr-treated cell. The inset in panel D shows an enlargement of a region proximal to the plasma membrane. Thin arrows indicate extracellular Ad2 particles, large arrows indicate cytoplasmic Ad2, small arrowheads show coated vesicles containing Ad2 (A) and also Ad2 particles within small vesicles (D), and the large arrowhead depicts Ad2 within a medium-sized vesicle (D), while * indicates a large vesicle (D). Note the enrichment of Ad2 particles in plasma membrane invaginations of cells treated with the actin stabilizer Jas (C) and the localization of Ad2 within small vesicles of PKC-myr-treated cells (D). Bar = 500 nm.

View larger version (24K): [in this window] [in a new window]   FIG. 6.   Quantification of Ad2 particles at the plasma membrane, in intracellular vesicles, and in the cytoplasm of HeLa cells treated with actin- and PKC-directed drugs or not treated. HeLa cells were infected and analyzed by thin-section EM as in Fig. 5. (A) Control cells. (B) CD-treated cells. (C) Jas-treated cells. (D) PKC-myr-treated cells. Viruses were counted in smooth (sh), invaginated (iv), and coated-pit (cp) regions of the plasma membrane, within small (s), medium (m), or large (l) vesicles, and also in the cytosol (solid bars). The number of Ad particles on the entire plasma membrane (open bars) and within the entire vesicle population (striped bars) is also indicated (tot). Mean values are expressed as the percentage of total virus particles, and the corresponding SEM values are indicated based on the analyzed number of cells (ranging from 11 to 14) and virus particles (ranging from 339 to 607). The corresponding number of electron micrographs (ranging from 90 to 179) is also indicated for each of the conditions.

Fiber release is not sufficient for virus escape from endosomes. Vitronectin is a physiological ligand of the Ad coreceptor _v5 integrin (39). Endocytosis of a conformationally altered vitronectin has been reported to be _v5 integrin dependent, and subsequent vitronectin degradation in lysosomes requires PKC (40). We therefore asked if HeLa cells treated with PKC inhibitors were able to induce fiber release from Ad2 and deliver Ad2 to the cytosol. As indicated in Fig. 1 (lanes 17 to 22), the PKC effector site inhibitor calphostin C or a competitive inhibitor for the ATP binding site BIM had no drastic effect on the efficiency of fiber release from [³⁵S]methionine-labeled Ad2, although both drugs slightly lowered the rate of fiber release. Likewise, the PKC inhibitors did not significantly affect the efficiency of Ad2 uptake at 30 min p.i., although they slightly reduced the internalization rate measured by the trypsin cleavage assay (Fig. 2D to F). Interestingly, the total amount of Ad2 associated with PKC-inhibited cells decreased to about 60% at 60 min p.i. whereas control cells contained 85% of the originally cell-bound virus (Fig. 2H). This loss of cell-associated virus was most probably not due to intracellular degradation, since we did not detect any of the typical hexon proteolysis products due to lysosomal degradation (20). It is possible that Ad2 was endocytosed and then delivered back to the surface, where it was removed by trypsin as originally described for ts1 Ad2 (20).

Fiber release correlates with virus shedding from the target cell. In cold-synchronized infections, Ad2 internalization coincides with the shedding of 15 to 20% of the cell-bound virus particles into the medium (21). To ask if virus shedding correlated with fiber release, we overexpressed dominant negative dynamin I K44A, which has a reduced rate of GTP hydrolysis affecting both clathrin- and non-clathrin-dependent endocytosis (13, 48) including Ad uptake and gene expression (58). K44A or wt dynamin I expression was induced by derepressing a transfected HeLa cell line for 4 days in tetracycline-free medium (13). The cells were then incubated with TR-labeled wt Ad2 for 1 h in the cold and warmed for 5 or 60 min. Cells overexpressing dominant negative dynamin were identified by the lack of internalized transferrin-Alexa 488, which was present during the warming period at 100 µg/ml. With this assay, we found that about 40% of the K44A dynamin I-transfected cells actually overexpressed the K44A mutant protein (data not shown). Total cell-associated Ad2-TR was then quantitated in single cells by fluorescence microscopy (37). At 5 and 60 min p.i., control cells expressing wt dynamin contained an average of 23 and 17 TR fluorescence units, respectively (Fig. 7A). The difference was significant (P = 0.05) and was in good agreement with earlier results measuring the dissociation of radiolabeled Ad2 particles from cells (21). In contrast, K44A dynamin-expressing cells contained similar amounts of Ad2-TR at 5 and 60 min p.i., namely, 12.4 and 10.7 fluorescence units per area (Fig. 7A). Likewise, there was no difference in the amount of cell-associated Ad2-TR on RGD peptide-incubated cells at 5 or 60 min p.i., suggesting that integrins are involved in the shedding of Ad2 (data not shown). Importantly, the mutant ts1 was not dissociated from wt or K44A dynamin-expressing cells (Fig. 7B), consistent with its failure to release fibers upon entry (20). Together, the data suggested that Ad2 shedding from the target cells required functional endocytosis and correlated with fiber release.

View larger version (27K): [in this window] [in a new window]   FIG. 7.   Dissociation of Ad2 from target cells requires functional dynamin. wt or ts1 Ad2-TR was bound in the cold to HeLa cells expressing either wt dynamin I (wt) or the GTP hydrolysis-defective K44A dynamin mutant. Following warming for 5 min (open bars) or 60 min (solid bars), cells were fixed and the cell-associated TR fluorescence was determined by FFT as described earlier (37). Results are expressed as mean values normalized to the corresponding cell areas including the SEM and the number of cells analyzed (n).

	DISCUSSION

Top Abstract Introduction Materials and Methods Results Discussion References

Despite ongoing progress in elucidating virus cell interactions, there are still major deficits in our understanding of Ad biology, including entry and disassembly of the capsid. In this study we have analyzed cellular factors involved in the initial step of Ad2 disassembly, the release of the fibers. Fiber release is a hallmark of the stepwise Ad disassembly program culminating in the dissociation of the capsid and the release of the viral DNA into the nucleoplasm (21, 55).

Surface events for fiber release. We show here that fiber release requires an intact actin cytoskeleton and proper contacts of the incoming capsid to cell surface integrins but is independent of virus endocytosis. Fiber release from incoming Ad2 capsids occurs at the plasma membrane following attachment of the distal fiber knob domains of virus to the surface receptor CAR (4, 15). The proximal fiber region is anchored in the capsid via the vertex protein penton base. While Ad2 binding to CAR occurs independently of physiological temperatures, fiber release requires warming of the cells and proper contacts of the penton base protein with cell surface integrins. These contacts can be inhibited by soluble RGD peptides or the calcium chelator EGTA inhibiting Ad2 endocytosis (19, 20, 62). These treatments also inhibit fiber release, suggesting that integrin contacts with the penton base in the context of CAR-bound virus can trigger the dissociation of fibers. It is possible but unlikely that the penton base is released together with fibers, since the penton base but not the fiber was detected by indirect immunofluorescence and cryoimmuno-EM on Ad particles near the nuclear envelope (data not shown). That the underlying actin cytoskeleton is also instrumental for fiber release is indicated by the strong inhibition of fiber release in cells treated with actin-destabilizing agents, including CD and latrunculin B (data not shown).

Relevance of fiber release. Fiber shedding at the cell surface may have several functions. The first function could be to promote capsid internalization independently of the primary receptor CAR or perhaps of major histocompatibility complex class I (4, 23, 56). It is not known whether the CAR receptor has the capacity to internalize, but the intracellular CAR domain is not required for infection (59). However, this does not exclude the notion that CAR remains permanently at the plasma membrane. Ad2 ts1 mutants bound to CAR-positive HeLa cells can be internalized without the apparent loss of fibers, indicating that fiber release is not required for interaction with an internalization receptor (20). Another reason why Ad2 would want to release its fibers at the surface could be to shed particles from a target cell and thus have the potential to infect neighboring cells expressing a different set of cell surface receptors. Fiber release is also associated with the ability of incoming Ad to escape from endosomes, as indicated by the results with the ts1 mutant, which fails to release fibers but enters by an integrin-dependent pathway (20, 29, 33). The reason for the failure of ts1 to release its fibers is not clear. Possibly, there are multiple contact sites between integrins and the penton base, one for uptake and another perhaps for fiber release. Alternatively, ts1 might fail to release its fibers due to its nonprocessed capsid structure or because it lacks contacts with unknown surface molecules.

PKC is required for vesicular trafficking and Ad escape from endosomes but not fiber release. Following fiber release, Ad is internalized by an integrin dependent pathway. Although fiber release per se is not required for internalization it may be required for capsid escape from endosomes. Carboxylic ionophores or primary amines neutralizing the acidic pH of intracellular compartments have no effects on the efficiency and the kinetics of fiber release (21), but they inhibit Ad escape from endosomes if the virus is present at low MOI (17, 46), suggesting that fiber release is not sufficient for Ad2 escape from endosomes. In contrast to pH-neutralizing procedures, inhibition of cellular PKCs was an effective treatment to limit Ad2 escape from endosomes even when Ad2 was present at high MOI. Given the observations that _v integrins contribute to Ad-mediated release of cytosolic contents (61) and PKC can be a downstream effector of _v integrins (38), it is possible that combined signaling of integrins and PKC activates a membrane lytic function effecting Ad release to the cytosol. Alternatively, but not exclusively, Ad2-mediated endosome lysis may require PKC-dependent trafficking of virus-containing endosomes and may be related to proper endosome acidification, which can be increased by PKC stimulation (63). This scenario would be in agreement with earlier studies suggesting that subgroup C Ads escape from a mildly acidic compartment, possibly the tubulovesicular early endosomal compartment (5, 22, 41), and that membrane trafficking in the cell periphery can be limited by the cortical actin cytoskeleton (16, 31, 35). Consistently, the early endosomal marker rab5 has been suggested to interact with actin filaments (36) and affect Ad5-mediated gene delivery (43). More recently, increasing evidence indicates that actin-dependent endocytic events in the cell cortex can also be regulated by calcium and PKC (38, 52). For example, movement of intracellular vesicles containing _v3 integrins seems to be affected by calcium (27), and calcium has been implicated in endosomal fusion (10). Given our observations that three different inhibitors of classical PKCs, namely, an ATP analogue (BIM), an effector site inhibitor (calphostin C), and a PKC pseudosubstrate mimicking the catalytic site (PKC-myr peptide), all inhibited Ad escape from endosomes without affecting virus endocytosis or fiber release, we speculate that a calcium-dependent classical PKC plays a role in peripheral trafficking of endocytic vesicles containing Ad2. In addition, our EM analysis indicated that the disruption of the actin cytoskeleton gave rise to a modest number of small peripheral endocytic vesicles containing Ad2, which were indistinguishable from those present in the PKC-inhibited cells. Together, these results may suggest that cytosolic calcium can be involved in Ad infection, despite the report that global calcium influx does not occur during the first 10 to 15 min of subgroup C Ad infections (43). It is, however, possible that local increases in the concentration of cytosolic calcium, perhaps in the vicinity of endocytic vesicles, are sufficient, together with additional unknown factors, to execute the proper endocytic trafficking and stimulate virus escape to the cytosol.